Kristin Arnold, Ph.D. has been appointed vice president of product development and technical services (PDTS) at Norwich Pharmaceuticals. Dr. Arnold will provide strategic leadership for the PDTS group that includes R&D, GMP pilot scale manufacturing, analytical development and validation, and testing services. She reports to chief executive officer, Doug Drysdale.
Prior to joining the company, Dr. Arnold held positions with URL Pharma as senior vice president of Product Development, Alpharma as senior director R&D, FMC Corp., Ecogen, and Monsanto.
"We are pleased to welcome Kristin Arnold to Norwich and look forward to her contributions to the PDTS group and the organization," said Mr. Drysdale. "Her expertise in product development from product conception through market launch will be an advantage for our customers and she will be a strong addition to our leadership team."